CIK 0001438533
- Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 262383102
- Phone
- +1 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,495,607
- in 10 filings, $79.5M under 10b5-1 plans
Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
- Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
- ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
- Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
- Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-08-15 | McFarlane Neil F. Chief Operating Officer | Grant or award | +15,000 | 15,000 | ||
| 2016-08-15 | McFarlane Neil F. Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2016-07-19 | Baynes Roy D. Director | Grant or award | +4,000 | 4,000 | ||
| 2016-07-19 | Baynes Roy D. Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2016-06-01 | Shih Alvin EVP of Research & Development | Sale | −8,750 | $17.75 | $155K | 167,084 |
| 2016-05-19 | Shih Alvin EVP of Research & Development | Grant or award · Employee stock option (right to buy) | +60,000 | 60,000 | ||
| 2016-05-19 | Clague Laura Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +60,000 | 60,000 | ||
| 2016-05-19 | ASELAGE STEVE Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +160,000 | 160,000 | ||
| 2016-05-18 | LYONS GARY A Director | Grant or award | +2,000 | 24,000 | ||
| 2016-05-18 | LYONS GARY A Director | Grant or award · Employee Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-05-18 | KOZARICH JOHN W Director | Grant or award | +2,000 | 22,000 | ||
| 2016-05-18 | KOZARICH JOHN W Director | Grant or award · Employee Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-05-18 | Golding Cornelius E Director | Grant or award | +2,000 | 29,000 | ||
| 2016-05-18 | Golding Cornelius E Director | Grant or award · Employee Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-05-18 | Coughlin Timothy P Director | Grant or award | +2,000 | 22,000 | ||
| 2016-05-18 | Coughlin Timothy P Director | Grant or award · Employee Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-05-18 | Meckler Jeffrey A Director | Grant or award | +2,000 | 54,000 | ||
| 2016-05-18 | Meckler Jeffrey A Director | Grant or award · Employee Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-03-04 | Meckler Jeffrey A Director | Purchase | +5,000 | $15.31 | $77K | 52,000 |
| 2016-03-03 | Meckler Jeffrey A Director | Purchase | +10,000 | $14.45 | $145K | 47,000 |
Page 54 of 59 · 1,174 trades